Oxford BioDynamics's market cap is currently £10.28M. The company's EPS TTM is p-0.007; its P/E ratio is ―; Oxford BioDynamics is scheduled to report earnings on June 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
